|
" First International Moxifloxacin Symposium Berlin, 1999 "
L Mandell
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
733007
|
| Doc. No
|
:
|
b552800
|
| Main Entry
|
:
|
L Mandell
|
| Title & Author
|
:
|
First International Moxifloxacin Symposium Berlin, 1999\ L Mandell
|
| Publication Statement
|
:
|
Berlin Springer Berlin, 2013
|
| Page. NO
|
:
|
XIII, 191 Seiten in 1 Teil XIII, 190 Seiten 235 x 155 mm
|
| ISBN
|
:
|
3642640818
|
|
|
:
|
: 9783642640810
|
| Contents
|
:
|
to the Symposium.- 1 - Antimicrobial Chemotherapy.- Antimicrobial Chemotherapy - Today.- Antimicrobial Chemotherapy - Tomorrow.- PART2-Pre-clinical.- Pre-clinical Microbiology - Streptococcus Pneumoniae.- Pre-clinical Microbiology - Gram-positive Cocci.- Pre-clinical Microbiology - Atypical Organisms.- Pre-clinical Microbiology - Summary I.- Pre-clinical Microbiology - Mycobacteria.- In-vitro Activity of Moxifloxacin [Bay 12-8039], an 8-methoxy Quinolone, Compared to Other Fluoroquinolones Against Anaerobic Bacteria.- Pre-clinical Microbiology - Fastidious Gram-negative Bacteria.- Pre-clinical Microbiology - Respiratory Tract Infections Susceptibility Survey - USA.- Pre-clinical Microbiology - Respiratory Tract Infections Susceptibility Survey - Europe.- Pre-clinical Microbiology - Respiratory Tract Infections Susceptibility Survey - Japan.- Mechanisms of Fluoroquinolone Action and Resistance.- Pre-clinical Microbiology - Summary II.- 3 - Pharmacology.- Pharmacokinetics and Pharmacodynamics of Antimicrobials.- Mini-Reviews - Pharmacokinetics/Pharmacodynamics (PK/PD).- In vitro Models as Predictors of the Antimicrobial Effect of Moxifloxacin and Other Fluoroquinolones.- In vitro Models of Infection - Pharmacokinetic/Pharmacodynamic Correlates.- Animal Model Experiences with Moxifloxacin.- Current Thinking About Pharmacokinetics and Pharmacodynamics of Antimicrobials.- Pharmacology of Moxifloxacin - Absorption, Distribution, Metabolism and Excretion.- Antimicrobial Drug-Drug Interations - Focus on Fluoroquinolones.- Pharmacology - Tissue Distribution.- Fluoroquinolones Phototoxicity - Moxifloxacin in Context.- Fluoroquinolone Safety and Tolerability.- 4 - Clinical Needs in the Millenium.- Clinical Needs in the Millenium - Community Acquired Pneumonia.- Clinical Needs in the Millenium - Pneumonia - The Role of Moxifloxacin.- Clinical Needs in the Millenium - Acute Exacerbations of Chronic Bronchitis.- Clinical Needs in the Millenium - Acute Exacerbations of Chronic Bronchitis - The Role of Moxifloxacin.- Clinical Needs in the Millenium - Rhinosinusitis.- Clinical Needs in the Millenium - Rhinosinusitis - The Role of Moxifloxacin.- Discussion on Clinical Needs in the Millenium.- 5 - Round Table Discussion.- Round Table Discussion - Introduction.- Round Table Discussion - Hospital Issues.- Round Table Discussion - Community Issues.
|
| LC Classification
|
:
|
RM666.M83L536 2013
|
| Added Entry
|
:
|
L Mandell
|
| |